Patheon
Globo Asiatico
Zuellig
Roche Diagnostics

ROCHE (PHILS), INC

Featured products of Roche
bevacizumab
Packing/Price
(vial) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC07 - bevacizumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC07 - bevacizumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
trastuzumab
Packing/Price
15 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC03 - trastuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
trastuzumab
Packing/Price
5 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC03 - trastuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
rituximab
Packing/Price
10 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC02 - rituximab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
rituximab
Packing/Price
50 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC02 - rituximab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
pertuzumab
Packing/Price
(single-use vial) 14 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC13 - pertuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
Distributor for Patheon
trastuzumab emtansine
Packing/Price
15 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC14 - trastuzumab emtansine : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
trastuzumab emtansine
Packing/Price
20 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC14 - trastuzumab emtansine : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
Distributed by Globo Asiatico
trastuzumab
Packing/Price
15 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC03 - trastuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
trastuzumab
Packing/Price
5 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC03 - trastuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
Distributed by Zuellig
bevacizumab
Packing/Price
(vial) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC07 - bevacizumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC07 - bevacizumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
rituximab
Packing/Price
10 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC02 - rituximab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
rituximab
Packing/Price
50 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC02 - rituximab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
pertuzumab
Packing/Price
(single-use vial) 14 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC13 - pertuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
Marketed for Roche Diagnostics
obinutuzumab
Packing/Price
50 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC15 - obinutuzumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.

Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in